FibroGen, Inc (FGEN): Price and Financial Metrics


FibroGen, Inc (FGEN)

Today's Latest Price: $44.35 USD

0.24 (-0.54%)

Updated Jan 17 4:00pm

Add FGEN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 322 in Biotech

See all "A" rated Strong Buy stocks

FGEN Stock Summary

  • FGEN's current price/earnings ratio is 88.65, which is higher than 92.31% of US stocks with positive earnings.
  • With a year-over-year growth in debt of -44.41%, Fibrogen Inc's debt growth rate surpasses merely 7.09% of about US stocks.
  • As for revenue growth, note that FGEN's revenue has grown 141.95% over the past 12 months; that beats the revenue growth of 95.83% of US companies in our set.
  • Stocks that are quantitatively similar to FGEN, based on their financial statements, market capitalization, and price volatility, are ARVN, MEIP, RARE, CUE, and TBPH.
  • FGEN's SEC filings can be seen here. And to visit Fibrogen Inc's official web site, go to www.fibrogen.com.
FGEN Daily Price Range
FGEN 52-Week Price Range

FGEN Stock Price Chart More Charts


FGEN Price/Volume Stats

Current price $44.35 52-week high $61.23
Prev. close $44.59 52-week low $32.33
Day low $44.30 Volume 835,095
Day high $45.21 Avg. volume 608,150
50-day MA $42.65 Dividend yield N/A
200-day MA $42.67 Market Cap 3.87B

FibroGen, Inc (FGEN) Company Bio


Fibrogen is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. The company was incorporated in 1993 and is based in San Francisco, California.





FGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

FGEN Latest Social Stream


Loading social stream, please wait...

View Full FGEN Social Stream

FGEN Price Returns

1-mo -4.11%
3-mo 14.30%
6-mo -4.07%
1-year -12.68%
3-year 87.53%
5-year 28.63%
YTD 3.40%
2019 -7.32%
2018 -2.36%
2017 121.50%
2016 -29.77%
2015 11.45%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6914 seconds.